ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 64 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 2.16 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $94,662,000 | -60.0% | 1,771,058 | -15.6% | 0.02% | -59.7% |
| Q4 2015 | $236,927,000 | -9.9% | 2,097,242 | -6.1% | 0.06% | -15.1% |
| Q3 2015 | $262,846,000 | +7.3% | 2,232,985 | -29.4% | 0.07% | +15.9% |
| Q2 2015 | $245,049,000 | +23.1% | 3,164,774 | -8.1% | 0.06% | +23.5% |
| Q1 2015 | $199,135,000 | +72.6% | 3,442,268 | -3.8% | 0.05% | +70.0% |
| Q4 2014 | $115,348,000 | -3.8% | 3,576,690 | -27.0% | 0.03% | -9.1% |
| Q3 2014 | $119,886,000 | +99.0% | 4,899,335 | +44.2% | 0.03% | +106.2% |
| Q2 2014 | $60,243,000 | -14.0% | 3,397,773 | -2.9% | 0.02% | -15.8% |
| Q1 2014 | $70,049,000 | +5.3% | 3,500,649 | -11.7% | 0.02% | 0.0% |
| Q4 2013 | $66,514,000 | +24.0% | 3,963,880 | -21.5% | 0.02% | +11.8% |
| Q3 2013 | $53,622,000 | +82.1% | 5,049,198 | -4.2% | 0.02% | +70.0% |
| Q2 2013 | $29,450,000 | – | 5,268,352 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |